Ms. Jenn Hepburn reports
EMERALD HEALTH THERAPEUTICS ANNOUNCES STOCK OPTION GRANT
Emerald Health Therapeutics Inc. has issued an aggregate of 3.8 million stock options to employees, consultants and directors at an exercise price of 21 cents per common share for a period of five years. All stock options will vest 25 per cent on the date of grant and 25 per cent on the first three anniversaries of the date of grant. Emerald has also granted an aggregate of 175,000 restricted share units to certain employees. The restricted share units will vest one year from the grant date and convert into common shares of Emerald at a fair market value of 21 cents per common share. The stock options and restricted share units have been granted pursuant to Emerald's omnibus incentive plan, which has been previously approved by Emerald's shareholders and the TSX Venture Exchange.
About Emerald Health Therapeutics Inc.
Emerald Health Therapeutics is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis and non-cannabis products, with an emphasis on life-science-based innovation and production excellence.
We seek Safe Harbor.
© 2021 Canjex Publishing Ltd. All rights reserved.